Tuesday, January 17, 2017

Treating Metabolic Conditions May Resolve Some Depressive Symptoms

New research suggests that treatable metabolic abnormalities underlie some treatment-resistant cases of depression—and treating the metabolic condition has the possibility of dramatically reducing depressive symptoms

Ruby Wax: From Shark Bait to the Doyenne of Disease

I ended 2016 as I started it: listening to a celebrity reducing the complex interplay between society and the psyche to a matter of simple biology. This deprives people of the opportunity to really understand their suffering and find meaning in it — and it undermines the case for prevention.

Healing Madness

After 35 years in medicine, and three years with the same large health care organization where I am now the Medical Director of Integrative Services, I have decided I must quit. I am not willing to be a part of any machine where I doubt in the benefit of what I am being asked to do, and fear it might even be making people sick.

MIA in the Year 2017

We have always conceived of Mad in America as a forum for a community to come together and “rethink” psychiatry and its current paradigm of care. This past year was our first operating as a 501c3, and the support we received from our readers and from charitable foundations has reinforced and strengthened this sense of our mission. As such, we thought it would be useful to briefly review how we expanded our operations in the past year, and detail our ambitions for 2017.

The NIMH in 2017: Looking for Love in All the Wrong Places

The official announcement of the NIMH's new director proudly proclaimed he had been studying things such as “the role of the hippocampus, a brain structure known to be important for memory and emotional processes associated with anxiety and depression.” Is there any evidence that anything will come of these theories — and the expenses demanded of such endeavors?

How Psychiatric Drugs Really Work

A case study of a former soldier illustrated that mefloquine can cause persisting brain injury with unrelenting, permanent emotional and cognitive problems. As my fellow psychiatrists commonly do, they diagnosed the former soldier with psychiatric disorders and treated him with multiple drugs, worsening his brain injury and overall mental condition.

The Biological Evidence for “Mental Illness”

Partners' comment in response to my Carrie Fisher article essentially consists of unsubstantiated assertions, non sequiturs, and appeals to psychiatric authority. Because it comes from, and presumably represents the views of, an extremely large psychiatric practice, it warrants a close look.

ARTWORK

by Kate
"Is it Prozac? Or Placebo?" by Kate

Most Popular

Provider Directory

A listing of individual practitioners, peer organizations, mutual support groups, and residential and outpatient programs that provide support for those looking to taper from psychiatric medications.

The Emperor’s New Drugs

Irving Kirsch reviews the ways in which studies of antidepressant medications have been flawed in both design and interpretation and describes how this has affected the FDA drug approval process.

Afiya Peer Respite House

A peer-run respite in Northampton, Ma.
FEATURED VIDEO
Will Hall at "Pharmaceuticals – Risks and Alternatives", 15th of October, 2016.
30:03
UCLA/ISEPP - Bob Fancher
30:21
Open Paradigm Project - Jenna Fogle
07:21
Jaakko Seikkula, PhD at "Pharmaceuticals – Risks and Alternatives," 15th of October, 2016.
37:41
Open Paradigm Project - Laura Nicole Sisson
08:02
Open Paradigm Project - Oryx Cohen
04:04
Forced Psychiatric Detention
18:37
Birgitta Alakare, MD at "Pharmaceuticals – Risks and Alternatives", 15th of October, 2016.
35:43
Sami Timimi, MD at "Pharmaceuticals – Risks and Alternatives", 15th of October, 2016.
46:06
Olga Runciman at "Pharmaceuticals – Risks and Alternatives," 15th of October, 2016
41:08
Open Paradigm Project - Will Eberle
07:46
Open Paradigm Project - Marty Hadge
04:30
"Moving Beyond Psychiatric Labels"
05:24
Carina Håkansson, PhD at "Pharmaceuticals – Risks and Alternatives", 15th of October, 2016.
39:26
John Read at "Pharmaceuticals – Risks and Alternatives," 15th of October, 2016.
40:54
Open Paradigm Project - Matt Samet
15:33
Open Paradigm Project - Sera Davidow
05:47
UCLA/ISEPP - Robert Whitaker
29:47
Open Paradigm Project - Amy Long
06:05
Open Paradigm Project - Leah Harris
08:43
UCLA/ISEPP - Allen Frances
23:09
Open Paradigm Project - Cheryl Sharp
06:04
Antidepressants & Pregnancy: The risks and potential harm to normal fetal development
01:38
UCLA/ISEPP - Peter Whitehouse
20:12
UCLA/ISEPP - David Healy
17:54
Open Paradigm Project - Faith Rhyne
06:07
Open Paradigm Project - Leonard Roy Frank
11:28
Open Paradigm Project - Dorothy Dundas
12:23
UCLA/ISEPP - Bonnie Burstow
25:16
Open Paradigm Project - Sean Donovan
06:09
UCLA/ISEPP - John Read
15:07
Open Paradigm Project - Celia Brown
07:16
Open Paradigm Project - Joanna Moncrieff
10:12
Interview with Bruce Levine
09:17
Open Paradigm Project - Iden McCollum
04:06
Interview with Peter Gøtzsche
15:46
About Mad in America (2013)
03:40
Mad in America's International Film Festival
03:22